4.
Multivariate regression analysis in predicting survival of 115 patients with NSCLC
| Stage Ⅰ | Stage Ⅱ | Stage Ⅲ | Stage Ⅳ | ||||||||
| Hazard ratio | P | Hazard ratio | P | Hazard ratio | P | Hazard ratio | P | ||||
| (95% CI) | (95% CI) | (95% CI) | (95% CI) | ||||||||
| cyclin D1 status | |||||||||||
| Low | 0.188 (0.055-0.650) | 0.008 | 0.587 (0.223-1.550) | 0.282 | 0.877 (0.377-2.403) | 0.762 | 3.362 (0.035-322.508) | 0.603 | |||
| High | |||||||||||
| Differentiation | |||||||||||
| Well/Moderate | 0.265 (0.091-0.772) | 0.015 | 0.325 (0.118-0.898) | 0.030 | 0.334(0.152-0.730) | 0.006 | 0.655 (0.014-30.822) | 0.830 | |||
| Poor | |||||||||||